MACUS T KUO to Skin Neoplasms
This is a "connection" page, showing publications MACUS T KUO has written about Skin Neoplasms.
Connection Strength
0.065
-
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. Br J Cancer. 2012 Apr 24; 106(9):1481-5.
Score: 0.032
-
The combination of ADI-PEG20 and TRAIL effectively increases cell death in melanoma cell lines. Biochem Biophys Res Commun. 2010 Apr 09; 394(3):760-6.
Score: 0.028
-
Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des. 2008; 14(11):1049-57.
Score: 0.006